CH641799A5 - Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents
Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. Download PDFInfo
- Publication number
- CH641799A5 CH641799A5 CH792079A CH792079A CH641799A5 CH 641799 A5 CH641799 A5 CH 641799A5 CH 792079 A CH792079 A CH 792079A CH 792079 A CH792079 A CH 792079A CH 641799 A5 CH641799 A5 CH 641799A5
- Authority
- CH
- Switzerland
- Prior art keywords
- propoxy
- group
- carbostyril
- cyclohexyltetrazol
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10786978A JPS5535019A (en) | 1978-09-01 | 1978-09-01 | Carbostyryl derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CH641799A5 true CH641799A5 (de) | 1984-03-15 |
Family
ID=14470137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH792079A CH641799A5 (de) | 1978-09-01 | 1979-08-31 | Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4277479A (nl) |
JP (1) | JPS5535019A (nl) |
AR (1) | AR229342A1 (nl) |
AT (1) | AT364363B (nl) |
AU (1) | AU538410B2 (nl) |
BE (1) | BE878548A (nl) |
CA (1) | CA1139761A (nl) |
CH (1) | CH641799A5 (nl) |
DE (1) | DE2934747A1 (nl) |
DK (1) | DK158788C (nl) |
ES (1) | ES483792A1 (nl) |
FI (1) | FI68398C (nl) |
FR (1) | FR2434809A1 (nl) |
GB (1) | GB2033893B (nl) |
IT (1) | IT1119929B (nl) |
MX (1) | MX6749E (nl) |
NL (1) | NL183888C (nl) |
NO (1) | NO153177C (nl) |
PH (1) | PH18452A (nl) |
PT (1) | PT70136A (nl) |
SE (1) | SE432252B (nl) |
SU (1) | SU1064868A3 (nl) |
ZA (1) | ZA794627B (nl) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57156469A (en) * | 1981-03-19 | 1982-09-27 | Otsuka Pharmaceut Co Ltd | Preparation of tetrazole derivative |
JPS57183761A (en) * | 1981-04-30 | 1982-11-12 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5859980A (ja) * | 1981-10-05 | 1983-04-09 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
JPS5877880A (ja) * | 1981-11-05 | 1983-05-11 | Otsuka Pharmaceut Co Ltd | テトラゾ−ル誘導体 |
DE3225169A1 (de) * | 1982-07-06 | 1984-01-12 | Basf Ag, 6700 Ludwigshafen | Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen |
US4803162A (en) * | 1984-05-15 | 1989-02-07 | Fluorodiagnostic Limited Partners | Composition, article and process for detecting a microorganism |
NZ212209A (en) * | 1984-05-29 | 1988-08-30 | Pfizer | Quinolone derivatives and pharmaceutical compositions |
GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
DK167187A (da) | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
JPH0681727B2 (ja) * | 1986-04-02 | 1994-10-19 | 大塚製薬株式会社 | 血小板粘着抑制剤 |
KR940000785B1 (ko) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | 카르보스티릴 유도체 및 그의 염의 제조 방법 |
JPH0681752B2 (ja) * | 1986-04-02 | 1994-10-19 | 大塚製薬株式会社 | カルボスチリル誘導体 |
JP2753622B2 (ja) | 1988-05-02 | 1998-05-20 | 大塚製薬株式会社 | カルボスチリル誘導体 |
US5064837A (en) * | 1989-11-13 | 1991-11-12 | Schering Corporation | 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions |
DE69014867T2 (de) * | 1990-01-08 | 1995-07-06 | Otsuka Pharma Co Ltd | Zusammensetzung eines haartonikums sowie eines haarpflegemittels. |
TW201305B (nl) * | 1991-04-03 | 1993-03-01 | Otsuka Pharma Co Ltd | |
AU653060B2 (en) * | 1991-08-23 | 1994-09-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative and platelet agglutination inhibitor |
JPH0776521A (ja) * | 1993-09-07 | 1995-03-20 | Otsuka Pharmaceut Co Ltd | 気道炎症抑制剤 |
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
JP4060523B2 (ja) * | 1999-11-24 | 2008-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
US20030045547A1 (en) | 2001-05-02 | 2003-03-06 | Shinji Aki | Process for producing carbostyril derivatives |
US6515128B2 (en) | 2000-03-20 | 2003-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
IL151838A0 (en) | 2000-03-20 | 2003-04-10 | Teva Pharma | Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n- (4-methoxyphenyl)-3-chloropropionamide |
US6825214B2 (en) * | 2000-08-14 | 2004-11-30 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
PL365672A1 (en) * | 2000-08-14 | 2005-01-10 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US6458804B1 (en) | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
US7399864B2 (en) * | 2001-05-02 | 2008-07-15 | Otsuka Pharmaceutical Co., Ltd. | Process for producing carbostyril derivatives |
US20050101631A1 (en) * | 2002-08-01 | 2005-05-12 | Otsuka Pharmaceuticals Company | Process for producing carbostyril derivatives |
JP2003063965A (ja) * | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
US6531603B1 (en) * | 2001-06-29 | 2003-03-11 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6573382B2 (en) * | 2001-06-29 | 2003-06-03 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
WO2003002121A1 (en) * | 2001-06-29 | 2003-01-09 | Aaipharma, Inc. | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
US6388080B1 (en) | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6657061B2 (en) * | 2001-06-29 | 2003-12-02 | Grayson Walker Stowell | Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US6596871B2 (en) * | 2001-06-29 | 2003-07-22 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
AU2002322456A1 (en) * | 2001-06-29 | 2003-03-03 | Aaipharma, Inc. | Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone |
US6660864B2 (en) * | 2001-06-29 | 2003-12-09 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
SI1489080T1 (sl) * | 2002-09-10 | 2011-05-31 | Otsuka Pharma Co Ltd | Postopek za pridobivanje cilostazola |
US6743806B2 (en) * | 2002-10-23 | 2004-06-01 | Otsuka Pharmaceutical Company, Limited | Active oxygen scavenger |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
ITMI20031670A1 (it) * | 2003-08-26 | 2005-02-27 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Processo per la preparazione di cilostazolo e di suoi intermedi. |
US7524960B2 (en) * | 2004-03-16 | 2009-04-28 | Chemagis Ltd. | Highly pure cilostazol and an improved process for obtaining same |
US20050255155A1 (en) * | 2004-05-11 | 2005-11-17 | Glenmark Pharmaceuticals Limited | Modified release cilostazol compositions |
EP1802304A1 (en) * | 2004-09-17 | 2007-07-04 | Ranbaxy Laboratories Limited | Cilostazol-containing pharmaceutical composition based on particles of less than 50 micrometers |
CN100462360C (zh) * | 2005-08-15 | 2009-02-18 | 上海立科药物化学有限公司 | N-环己基-5-(4-氯丁基)-1h-四氮唑的合成方法 |
KR101299320B1 (ko) | 2005-09-15 | 2013-09-03 | 오츠카 세이야쿠 가부시키가이샤 | 초과산화물 억제제 효과를 갖는 프로부콜 및테트라졸릴알콕시-디히드로카르보스티릴 유도체를 함유하는조합 약물 |
US20070105898A1 (en) * | 2005-11-09 | 2007-05-10 | Apotex Pharmachem Inc. | Process for the production of cilostazol |
AR065588A1 (es) | 2007-03-09 | 2009-06-17 | Otsuka Pharma Co Ltd | Un medicamento para tratar enfermedad pulmonar obstructiva cronica |
TW200848041A (en) | 2007-03-30 | 2008-12-16 | Otsuka Pharma Co Ltd | A medicament for treating schizophrenia comprising cilostazol |
EP2152689B1 (en) * | 2007-04-25 | 2013-01-02 | Concert Pharmaceuticals Inc. | Analogues of cilostazol |
US8349817B2 (en) * | 2007-04-25 | 2013-01-08 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
WO2008143361A1 (en) | 2007-05-22 | 2008-11-27 | Otsuka Pharmaceutical Co., Ltd. | A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
EP2194048A1 (en) | 2008-12-02 | 2010-06-09 | Dirk Sartor | Nitrate esters for the treatment of vascular and metabolic diseases |
CN102933205B (zh) | 2010-04-28 | 2014-08-13 | 诺弗米克斯有限公司 | 西洛他唑共晶和组合物 |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
ES2664873T3 (es) | 2011-03-01 | 2018-04-23 | Synergy Pharmaceuticals Inc. | Proceso de preparación de agonistas de guanilato ciclasa C |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
KR20220147691A (ko) | 2013-08-09 | 2022-11-03 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス, インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2470084A (en) * | 1945-09-25 | 1949-05-17 | Bilhuber Inc E | Substituted alpha-halogen alkyl tetrazoles and process for obtaining the same |
US2470085A (en) * | 1947-03-07 | 1949-05-17 | Bilhuber Inc E | Substituted amino alkyl tetrazoles |
AR207554A1 (es) * | 1972-12-02 | 1976-10-15 | Otsuka Pharma Co Ltd | Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2) |
JPS5310986B2 (nl) * | 1974-02-05 | 1978-04-18 | ||
JPS5310989B2 (nl) * | 1974-04-25 | 1978-04-18 | ||
US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
FI58329C (fi) * | 1974-11-08 | 1981-01-12 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat |
US4129565A (en) * | 1975-07-11 | 1978-12-12 | Nisshin Flour Milling Co., Ltd. | Isocarbostyril derivatives |
US4210753A (en) * | 1976-03-17 | 1980-07-01 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds |
JPS52116482A (en) * | 1976-03-24 | 1977-09-29 | Otsuka Pharmaceut Co Ltd | Carbostyril derivatives and its preparation |
JPS5430183A (en) * | 1977-08-10 | 1979-03-06 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril derivative |
-
1978
- 1978-09-01 JP JP10786978A patent/JPS5535019A/ja active Granted
-
1979
- 1979-08-22 CA CA000334272A patent/CA1139761A/en not_active Expired
- 1979-08-28 DE DE19792934747 patent/DE2934747A1/de active Granted
- 1979-08-29 AR AR277883A patent/AR229342A1/es active
- 1979-08-29 US US06/070,710 patent/US4277479A/en not_active Expired - Lifetime
- 1979-08-29 PH PH22976A patent/PH18452A/en unknown
- 1979-08-29 AU AU50397/79A patent/AU538410B2/en not_active Expired
- 1979-08-30 DK DK363179A patent/DK158788C/da active
- 1979-08-30 NL NLAANVRAGE7906523,A patent/NL183888C/nl not_active IP Right Cessation
- 1979-08-30 FI FI792699A patent/FI68398C/fi not_active IP Right Cessation
- 1979-08-30 SU SU792804457A patent/SU1064868A3/ru active
- 1979-08-31 IT IT68748/79A patent/IT1119929B/it active
- 1979-08-31 SE SE7907236A patent/SE432252B/sv not_active IP Right Cessation
- 1979-08-31 NO NO792829A patent/NO153177C/no unknown
- 1979-08-31 CH CH792079A patent/CH641799A5/de not_active IP Right Cessation
- 1979-08-31 ZA ZA00794627A patent/ZA794627B/xx unknown
- 1979-08-31 ES ES483792A patent/ES483792A1/es not_active Expired
- 1979-08-31 BE BE0/196976A patent/BE878548A/xx not_active IP Right Cessation
- 1979-08-31 MX MX798357U patent/MX6749E/es unknown
- 1979-08-31 PT PT70136A patent/PT70136A/pt unknown
- 1979-08-31 FR FR7921869A patent/FR2434809A1/fr active Granted
- 1979-09-03 GB GB7930520A patent/GB2033893B/en not_active Expired
- 1979-09-03 AT AT0584579A patent/AT364363B/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH641799A5 (de) | Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
DE2825048C2 (nl) | ||
DE3152880C2 (nl) | ||
EP0207331B1 (de) | Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
DE2560549C2 (nl) | ||
DE1620740C3 (de) | Substituierte Tetrahydro-6-Sulfamyl-chinazolinone und diese Verbindungen enthaltende pharmazeutische Präparate | |
EP0000113B1 (de) | Dihydropyridazone, ihre Herstellung und sie enthaltende Arzneimittel sowie Dihydropyridazone zur Verwendung für therapeutische Behandlung | |
DE2559509A1 (de) | Benzcyloamidderivate und verfahren zu ihrer herstellung sowie pharmazeutische mittel, worin sie enthalten sind | |
CH644116A5 (de) | Imidazolderivate. | |
CH626612A5 (nl) | ||
DE68925270T2 (de) | Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel | |
DE2705778C2 (nl) | ||
DE3049959C2 (nl) | ||
DE3940021C2 (de) | Adenosin-Derivate, deren Herstellung und Verwendung | |
EP0001108B1 (de) | Neue 1,4-Dihydropyridazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
EP0071102B1 (de) | Neue Benztriazole, ihre Herstellung und ihre Verwendung als Arzneimittel | |
DE2427207A1 (de) | Verfahren zur herstellung von kondensierten pyrrolmercapto-verbindungen | |
DE3512629C2 (de) | s-Triazolo[1,5-a]pyrimidine und Verfahren zu ihrer Herstellung | |
DE3223877C2 (nl) | ||
DE3874465T2 (de) | 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel. | |
EP0180833B1 (de) | 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel | |
EP0324988B1 (de) | 4-Chlor-3-sulfamoyl-benzoesäure-hydrazide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittelpräparate und Verwendung der neuen Verbindungen zur Herstellung von diuretischen und salzentziehend wirkenden Arzneimittelpräparaten | |
DE2322350A1 (de) | 1,8-naphthyridin-2(1h)-on-derivate und verfahren zu ihrer herstellung | |
DE2732951A1 (de) | Neue imidazo-isochinolin-dione | |
DE2837236A1 (de) | Indolopyrone und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |